Home › Glomerulonephritis
Glomerulonephritis clinical trials recruiting in the U.S.
9 studies for Glomerulonephritis are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria
Recruiting
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07431931Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
RecruitingPhase 3
Ages 2 to 18 · All sexes · Updated Nov 6, 2026 · NCT07498335A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07902817A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
RecruitingPhase 2
Ages 18 to 60 · All sexes · Updated Oct 30, 2026 · NCT07541287A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Oct 5, 2026 · NCT04557462PS-002 for the Treatment of IgA Nephropathy in Adults
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07182227Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Aug 17, 2026 · NCT06858319Atacicept in Multiple Glomerular Diseases
RecruitingPhase 2
Ages 2 and older · All sexes · Updated Jun 26, 2026 · NCT06983028Study of BHV-1400 in IgA Nephropathy
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jun 23, 2026 · NCT07054684From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.